Advertisement

Topics

Companies Related to "Resistance to Aspirin and/or Clopidogrel Among Patients With PAD." [Most Relevant Company Matches] - Page: 2 RSS

10:34 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Resistance to Aspirin and/or Clopidogrel Among Patients With PAD." found in our extensive corporate database of over 50,000 company records.

Showing "Resistance Aspirin Clopidogrel Among Patients With" Companies 26–50 of 3,900+

Probably Relevant

Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a ...


Memgen, LLC

Memgen is a clinical-stage biotechnology company developing immunotherapies to improve survival and quality of life of patients with cancer, autoimmune conditions and infectious diseases. Memgen’s patent-protected, re-engineered molecules, which are based on the tumor necrosis factor (TNF) superfamily of molecules, target specific receptors express...

The Chiron Clinic

We are a complementary clinic run by medical doctors. However our doctors have also combined extensive additional complementary training and practise with their original orthodox skill. This makes us part of that very rare and specialist group of fully complementary medical doctors The outcome of this “integration of skills” is that we feel obliged to assess patients in a holistic manner, as t...


MicroPhage

Based in Longmont, Colorado, and privately held MicroPhage, Inc. is working to be a global leader in developing rapid diagnostics products for bacterial identification and antibiotic susceptibility/resistance testing. Using its proprietary Bacteriophage Amplification platform, the Company has developed a patented process that is a product platform for rapi...

SpeeDx Pty. Ltd.

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven...

Medality Medical LLC

Medality Medical LLC, a privately funded (including an NIH grant) medical technology company, is focused on reversing type 2 diabetes and associated obesity. Its patented proprietary technology enables the gentle and selective extraction of excess mesenteric visceral fat, which has been associated with insulin resistance, a precursor to type 2 diabetes. In...

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is engaged in the discovery and commercialization of new therapeutics that treat serious and life-threatening diseases, with a particular focus on the growing worldwide problem of antibiotic resistance. Paratek is advancing novel compounds that can circumvent or block bacterial resistance involving technology initially developed by Paratek co-founder Dr. Stuart Levy's...

Mpex Pharmaceuticals

Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens. It is well documented that antibiotic resistance is a growing, serious problem in both the hospital and community setting. Mpex's approach is to improve the activity of existing antibiotics by utilizing methods and pot...

Notable Labs

Notable Labs’ mission is to change the way cancer is treated, which starts with putting patients first. The company is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the c...

TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have ...

Glucox Biotech AB

The primary goal of Glucox Biotech is to develop a clinically applicable therapeutic drug for treatment of type 2 diabetes and insulin resistance. The highly favorable benefits of Glucox Biotech therapy is to decrease the critical risks and delay progression of the complications in Type 2 Diabetes patients by improving glycemic blood control. Based on its scientific excellence and with a strong mi...

Spirogen and BioAtla

Spirogen Limited (“Spirogen”) was founded in 2001 as a spin-out from several institutions including University College, London. Since that time, it has developed a novel class of highly potent cytotoxic warheads based on its proprietary pyrrolobenzodiazepines (“PBD’s”), DNA minor groove binding agents, which bind and cross-link specific s...

AdvanDx, Inc

AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE™ kits for detecting specific antibiotic resistance, virulence, and toxicity markers such as methicillin-resistance, vancomycin-resistance, PVL and TSST-1 in Staphylococcus aureus and enterococci, were launched for research use only in the United States. EVIGENE was officially launch...

PLANTON GmbH

Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. ...

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...

Otonomy Inc.

Otonomy is an emerging biopharmaceutical company based in San Diego that is focused on the development and commercialization of novel treatments for diseases of the inner and middle ear. This field represents a large untapped opportunity with nearly 30 million Americans facing debilitating hearing and balance disorders. Currently, no approved drug treatments exist for these conditions. In addition...

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patie...

Arsanis Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Arsanis, Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Arsanis Biosciences GmbH

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Arsanis, Inc.

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Company’s major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...

Athenix provides genes

Athenix provides genes, proteins, traits, and transgenic organisms for multiple industry sectors including seed, agricultural chemicals, specialty chemicals, industrial enzymes, energy and feed.Our core technology platform is centered on high throughput microbial screens and focused genomic sequencing.Our product platforms include microbial strain improvement and genetic engineering of microbes an...

Max Planck Institute for Plant Breeding Research

The Max Planck Institute for Plant Breeding Research conducts basic molecular biological research on plants with the goal of developing more efficient breeding techniques and environmentally sound plant protection strategies for industrial crops. Four research departments focus inquiry on the evolution of plants, genetic makeup, development, and environmental interaction. Researchers in the Depart...

The Patients Association

The Patients Association is a registered charity, staffed by paid and unpaid staff. The Patients Association offers patients an opportunity to share their experiences of health services. The Patients Association uses the knowledge it gains from patients to work with the NHS and other healthcare providers to improve services. The Patients Association works with a range of organisations providing he...

Bayer CropScience

For most people, taking a Bayer Aspirin is the initial introduction to our company. But products made by Bayer are found not just in medicine cabinets but in nearly every bedroom, living room, kitchen, garage, hospital, farm and factory across America. Our products help preserve local landmarks, advance automobile safety and durability, diagnose and treat disease, and protect crops, homes and pets...


More From BioPortfolio on "Resistance to Aspirin and/or Clopidogrel Among Patients With PAD."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks